Arcadia Biosciences, Inc. (RKDA) financial statements and ratios from SEC XBRL: revenue $4.86M (TTM), net margin -48.1%, revenue growth -3.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.86M |
| Net Margin | -48.1% |
| Revenue Growth (YoY) | -3.7% |
| EPS Growth (YoY) | -66.9% |
| FCF Growth (YoY) | -50.9% |
| Price / Book | 2.74 |
| Price / Sales | 0.35 |
| Altman Z-Score | -59.51 (distress) |
| Sector P/E (Energy) | 16.5 |
RKDA overview · RKDA earnings · RKDA KPIs · RKDA investor relations · RKDA ownership · RKDA peers · RKDA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.